Comparison of eptifibatide and abciximab in the in-hospital outcomes and thrombocytopenia during percutaneous coronary intervention

被引：0
|
作者：
Suleiman, M [1 ]
Gruberg, L [1 ]
Halabi, M [1 ]
Nikolsky, E [1 ]
Grenadier, E [1 ]
Boulus, M [1 ]
Markiewicz, W [1 ]
Beyar, R [1 ]
机构：
[1] Rambam Med Ctr, Dept Cardiol, Haifa, Israel
来源：
EUROPEAN HEART JOURNAL | 2002年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：434 / 434
页数：1
相关论文
共 50 条
  • [21] Gender impact on in-hospital outcomes after percutaneous coronary intervention
    Cardoso, Cristiano Oliveira
    Cardoso, Carlos Roberto
    Rodrigues, La Hore Correa
    Staudt, Clacir
    Miller, Vasco Morosini
    Somavilla Duarte, Aldo Fernando
    Cabrera Yordi, Luis Maria
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 133 (01) : 106 - 109
  • [22] In-hospital outcomes of emergent and elective percutaneous coronary intervention in octogenarians
    Merchant, Faisal M.
    Weiner, Rory B.
    Rao, Sowmya R.
    Lawrence, Ryan
    Healy, Joanne L.
    Pomerantsev, Eugene
    Rosenfield, Kenneth
    Jang, Ik-Kyung
    CORONARY ARTERY DISEASE, 2009, 20 (02) : 118 - 123
  • [23] In-hospital outcomes and mortality in octogenarians after percutaneous coronary intervention
    Rynkowska-Kidawa, Monika
    Zielinska, Marzenna
    Chizynski, Krzysztof
    Kidawa, Michal
    KARDIOLOGIA POLSKA, 2015, 73 (06) : 396 - 403
  • [24] Eptifibatide and Abciximab are associated with similar outcomes when used during Primary Percutaneous Coronary Intervention for ST-elevation myocardial infarction
    Ding, Nicola
    Jones, Daniel A.
    Peterzan, Mark
    Gallagher, Sean
    Antoniou, Sotiris
    Wright, Paul
    Rathod, Krishnaraj
    Jain, Ajay
    Knight, Charles
    Mathur, Anthony
    Weerackody, Roshan
    Wragg, Andrew
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : B48 - B48
  • [25] Eptifibatide and abciximab are associated with similar outcomes when used during primary percutaneous coronary intervention for ST-elevation myocardial infarction
    Akhtar, M. M.
    Jones, D. A.
    Ding, N.
    Gallagher, S.
    Rathod, K. S.
    Jain, A.
    Knight, C.
    Mathur, A.
    Weerackody, R.
    Wragg, A.
    EUROPEAN HEART JOURNAL, 2013, 34 : 1024 - 1025
  • [26] Eptifibatide and percutaneous coronary intervention
    Haude, M
    HERZ, 2004, 29 (07) : 649 - 650
  • [27] Effectiveness of tirofiban, eptifibatide, and abciximab in minimizing myocardial necrosis during percutaneous coronary intervention (TEAM pilot study)
    Kini, AS
    Richard, M
    Suleman, J
    Perez, N
    Lee, P
    Fisher, EA
    Kamran, M
    Marmur, JD
    Sharma, SK
    AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (05): : 526 - +
  • [28] Adverse outcomes in patients experiencing thrombocytopenia following percutaneous coronary intervention: a pooled analysis of abciximab studies
    Jamal, HH
    Gu, X
    Reid, PR
    EUROPEAN HEART JOURNAL, 2003, 24 : 541 - 541
  • [29] In-hospital outcomes in nonagenarian patients undergoing primary percutaneous coronary intervention
    Angelini, Filippo
    Franchin, Luca
    Bocchino, Pier P.
    Morici, Nuccia
    Wanha, Wojciech
    Savonitto, Stefano
    Trabattoni, Daniela
    Cerrato, Enrico
    Barbieri, Lucia
    Fortuni, Federico
    De Luca, Leonardo
    Greco, Antonio
    De Filippo, Ovidio
    Montefusco, Antonio
    Montabone, Andrea
    Rubino, Anna E.
    Gili, Sebastiano
    Quadri, Giorgio
    Somaschini, Alberto
    Cornara, Stefano
    Carugo, Stefano
    Capodanno, Davide
    Wojakowski, Wojciech
    Dusi, Veronica
    D'Ascenzo, Fabrizio
    De Ferrari, Gaetano M.
    MINERVA CARDIOLOGY AND ANGIOLOGY, 2023, 71 (05) : 590 - 598
  • [30] Percutaneous coronary intervention and in-hospital outcomes in patients with leukemia: a nationwide analysis
    Potts, Jessica
    Mohamed, Mohamed O.
    Mattei, Juan C. Lopez
    Iliescu, Cezar A.
    Konopleva, Marina
    Rashid, Muhammad
    Bagur, Rodrigo
    Mamas, Mamas A.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2020, 96 (01) : 53 - 63
12345